Vertex Pharmaceuticals Inc (VRTX)

239.09
+10.87(+4.76%)
  • Volume:
    2,046,484
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    227.18 - 240.77

VRTX Overview

Prev. Close
228.22
Day's Range
227.18-240.77
Revenue
7.57B
Open
227.36
52 wk Range
176.36-240.77
EPS
9.03
Volume
2,046,484
Market Cap
60.8B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,910,338
P/E Ratio
25.28
Beta
0.57
1-Year Change
1.32%
Shares Outstanding
254,500,000
Next Earnings Date
27 Apr 2022
What is your sentiment on Vertex Pharmaceuticals Inc?
or
Vote to see community's results!

Vertex Pharmaceuticals Inc Company Profile

Employees
3400

Vertex Pharmaceuticals Incorporated is a biotechnology company. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI and KALYDECO. It offers its products to treat people with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. Its CFTR correctors, such as lumacaftor, tezacaftor, and elexacaftor, help CFTR proteins reach the cell surface. It offers pipeline of small molecule medicines in other serious diseases where it has insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyStrong Buy
SummarySellStrong BuyStrong BuyStrong BuyStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.